ICICI Prudential NASDAQ 100 Index Fund vs ICICI Prudential Nifty Pharma Index Fund
ICICI Prudential NASDAQ 100 Index Fund (Direct) and ICICI Prudential Nifty Pharma Index Fund (Direct) head to head: growth of ₹100, returns across every window, risk, cost, and portfolio overlap — every figure computed from AMFI NAV history, nothing supplied by a fund house. Both are Index Funds schemes — see the best index funds for the full ranking.
Head to head
NAVs as of 23 Oct 2026
Growth of ₹100 (rebased over the selected window)
Common period 15 Dec 2022 – 22 Oct 2026, limited by ICICI Prudential Nifty Pharma Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | ICICI Prudential NASDAQ 100 Index Fund | ICICI Prudential Nifty Pharma Index Fund | Nasdaq 100 (₹, price) | Nifty Pharma TRI |
|---|---|---|---|---|
| 15 Dec 2022 | ₹100.00 | ₹100.00 | ₹100.00 | ₹100.00 |
| 11 Apr 2023 | ₹113.64 | ₹96.15 | ₹113.66 | ₹96.30 |
| 07 Aug 2023 | ₹136.29 | ₹120.63 | ₹136.20 | ₹121.58 |
| 02 Dec 2023 | ₹142.68 | ₹126.22 | ₹142.45 | ₹128.04 |
| 28 Mar 2024 | ₹162.80 | ₹147.42 | ₹162.57 | ₹149.97 |
| 23 Jul 2024 | ₹176.73 | ₹160.94 | ₹176.65 | ₹164.20 |
| 18 Nov 2024 | ₹185.45 | ₹166.95 | ₹185.36 | ₹170.77 |
| 15 Mar 2025 | ₹179.63 | ₹158.24 | ₹182.97 | ₹161.92 |
| 10 Jul 2025 | ₹209.56 | ₹171.62 | ₹209.09 | ₹175.72 |
| 04 Nov 2025 | ₹241.39 | ₹173.70 | ₹241.09 | ₹178.19 |
| 02 Mar 2026 | ₹244.75 | ₹178.70 | ₹243.18 | ₹183.55 |
| 27 Jun 2026 | ₹297.86 | ₹194.22 | ₹293.65 | ₹200.08 |
| 22 Oct 2026 | ₹293.23 | ₹199.32 | ₹291.77 | ₹205.49 |
Portfolio overlap (same stocks held through more than one fund)
Some overlap is structural: SEBI defines large cap as the top 100 stocks by market capitalisation, so two large-cap funds are fishing the same pond by regulation. The bands below are measured per sleeve pairing rather than against one blanket threshold. How this is measured →
- 101 stocks only in ICICI Prudential NASDAQ 100 Index Fund
- 0 stocks in both — 0.0% of each portfolio by weight
- 20 stocks only in ICICI Prudential Nifty Pharma Index Fund
The more the circles overlap, the more the funds hold the same stocks.
ICICI Prudential NASDAQ 100 Index Fund and ICICI Prudential Nifty Pharma Index Fund share 0% of their equity book by weight.
| Metric | ICICI Prudential · Direct NAV ₹23.84 Very High risk Unrated | ICICI Prudential · Direct NAV ₹19.61 Very High risk ★★★★★ |
|---|---|---|
| +23.95%Best in row | +12.79% | |
| +31.22%Best in row | +19.38% | |
| +19.00% | — | |
| +18.78% | +19.27% | |
| +26.85% | — | |
| +27.08%Best in row | +21.93% | |
| +19.00% | — | |
| Risk | ||
| 21.43% | 15.14%Best in row | |
| 1.15Best in row | 0.85 | |
| 1.71Best in row | 1.22 | |
| -30.04% | -16.59% | |
| Nasdaq 100 (₹, price) | Nifty Pharma TRI | |
| +0.97%Best in row | -0.67% | |
| 0.96 | 1.00 | |
| 98.7% | 99.2% | |
| 94.8%Best in row | 102.3% | |
| 0.63% | 0.51%Best in row | |
| ₹3,572Cr | ₹150.77Cr | |
| ₹100 | ₹1.00K | |
| 18% | 26% | |
| Sharmila Dmello · 4.6y | Nishit Patel | |
| 18 Oct 2021 | 14 Dec 2022 | |
| 101 | 20 | |
| 46.8% | 78.2% | |
6 rows carry the same value for every fund — show
- 10Y return (CAGR)
- —
- 10Y rolling avg
- —
- Exit load
- None
- Lock-in
- None
- Min lumpsum
- ₹1.00K
- Cash & equivalents
- 0.1%
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.
Frequently asked questions
Which fund has delivered higher returns — ICICI Prudential NASDAQ 100 Index Fund or ICICI Prudential Nifty Pharma Index Fund?
Over the last 3 years, ICICI Prudential NASDAQ 100 Index Fund returned +31.22% CAGR against ICICI Prudential Nifty Pharma Index Fund's +19.38%, computed from AMFI NAV history. Past returns don't guarantee future performance.
Which fund is cheaper — ICICI Prudential NASDAQ 100 Index Fund or ICICI Prudential Nifty Pharma Index Fund?
ICICI Prudential Nifty Pharma Index Fund has the lower expense ratio: ICICI Prudential NASDAQ 100 Index Fund charges 0.63% a year against ICICI Prudential Nifty Pharma Index Fund's 0.51%. The expense ratio is deducted from the NAV daily, so a lower one compounds in the investor's favour.
Which fund is riskier — ICICI Prudential NASDAQ 100 Index Fund or ICICI Prudential Nifty Pharma Index Fund?
ICICI Prudential NASDAQ 100 Index Fund has shown higher volatility (+21.43% annualized vs ICICI Prudential Nifty Pharma Index Fund's +15.14%), measured as the annualized standard deviation of daily returns over the trailing 3 years. Worst 3-year drawdown: ICICI Prudential NASDAQ 100 Index Fund -23.84% vs ICICI Prudential Nifty Pharma Index Fund -16.59%.
Which fund manages more money — ICICI Prudential NASDAQ 100 Index Fund or ICICI Prudential Nifty Pharma Index Fund?
ICICI Prudential NASDAQ 100 Index Fund is the larger fund: ICICI Prudential NASDAQ 100 Index Fund manages ₹3,572Cr against ICICI Prudential Nifty Pharma Index Fund's ₹150.77Cr in assets. Size cuts both ways — scale lowers costs, but a very large fund can find it harder to move in and out of positions.
Are ICICI Prudential NASDAQ 100 Index Fund and ICICI Prudential Nifty Pharma Index Fund in the same category?
Yes — both are Index Funds schemes, so their returns, risk and cost are directly comparable against the same peer set.
Figures update daily from AMFI NAV history; ratings and ranks are WealthTicker’s own — see the methodology. This is data, not investment advice.